Prana Biotechnology Ltd Sponsored ADR
(NASDAQ : PRAN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Loading PRAN News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
2.07%85.141.8%$761.49m
BIIBBiogen Inc.
1.43%245.281.0%$589.62m
CELGCelgene Corporation
2.56%101.151.2%$479.78m
AMGNAmgen Inc.
1.60%154.581.0%$457.27m
REGNRegeneron Pharmaceuticals, Inc.
2.47%357.873.1%$333.55m
ALXNAlexion Pharmaceuticals, Inc.
1.86%118.932.5%$317.30m
ILMNIllumina, Inc.
0.93%141.694.9%$171.29m
TSROTESARO, Inc.
-3.62%81.0115.8%$138.55m
VRTXVertex Pharmaceuticals Incorporated
2.50%88.172.6%$137.23m
BMRNBioMarin Pharmaceutical Inc.
4.27%81.124.0%$134.47m
MDVNMedivation, Inc.
-1.14%59.612.8%$131.44m
SRPTSarepta Therapeutics, Inc.
3.05%19.6549.4%$107.35m
AAgilent Technologies, Inc.
0.70%44.671.0%$105.11m
EXASExact Sciences Corporation
0.98%12.3721.4%$103.22m
ACADACADIA Pharmaceuticals Inc.
5.36%34.2019.6%$100.81m

Company Profile

Prana Biotechnology Ltd. engages in the development of therapies to treat neurodegenerative disease. It includes research and development of treatments for Alzheimer's and Huntington's disease. The company was founded by Geoffrey Paul Kempler on November 11, 1997 and is headquartered in Parkville, Australia.